Skip to content
Review

Non-Oncology Biomarkers in Precision Medicine: A Narrative Review.

Aug 2026 · Therapeutic Innovation and Regulatory Science · 0 citations · 54 references
Medicine

TL;DR

This narrative review explores the evolving role of biomarkers across cardiovascular, renal, neurological, metabolic, metabolic, and respiratory diseases, focusing on their clinical and regulatory contexts of use-diagnostic, prognostic, predictive, surrogate, safety, and pharmacodynamic/response.

View source

Similar papers

Review Open access 2026

Personalized Medicine in Oncology: Current Status and Future Prospects

The biological rationale rooted in the genomic basis of cancer and the concept of oncogene addiction is outlined, and the enabling technologies - next-generation sequencing, comprehensive genomic profiling, large reference atlases, and liquid biopsy - are described that have made molecular characterization feasible in...

Mohd Faizan Siddiqui · 0 citations
Review Open access Sep 2026

Circulating Biomarkers in Cardio-Oncology: Prediction and Prognostication

No single biomarker is sufficient to guide management across all clinical scenarios, however, a multimodal strategy incorporating biomarkers, imaging, and clinical assessment is increasingly recommended and standardization and validation of these strategies remains needed.

Jea-Eun Kim, B. Lee, Audrey White et al. · 0 citations
Review Sep 2026

Improving Patient Care in Modern Medicine: A Multidisciplinary Review of Diagnostic and Therapeutic Advances, Clinical Innovation, and Artificial Intelligence

Modern medicine is being reshaped by advances in diagnostics, therapeutics, precision medicine, digital health, and artificial intelligence (AI). This multidisciplinary review examines how these developments influence patient care across internal medicine, cardiology, neurology, oncology, obstetrics and gynecology, ped...

R. Manikandan · 0 citations
Review Open access Oct 2026

Artificial Intelligence in Precision Oncology Clinical Applications, Translational Challenges, and Future Directions

Background: Precision oncology aims to individualize cancer prevention, diagnostic stratifications, prognostication, and therapeutic regimens by synthesizing tumor biology with patient-specific clinical, demographic, and multi-omic characteristics. The exponential volume, velocity, and multi-scale complexity of contemp...

Goil Abhishek, Nrip Nripesh Kumar · 0 citations
Review Aug 2026

The Role of Biomarkers in Personalized Treatment of Gastrointestinal Cancers.

This narrative review examines the critical role of biomarkers in advancing personalized treatment strategies for GI cancers, highlighting biomarker-driven approaches across different GI cancer types and demonstrating how molecular profiling informs early detection, treatment selection, and monitoring of therapeutic re...

S. Mehrabadi · 0 citations
Open access Aug 2026

Towards Predictive, Preventive, and Participatory Care: The Promise of Personalized Medicine

Advances in next-generation sequencing, artificial intelligence, and additive manufacturing have driven pharmacogenomic drug optimization, biomarker-guided targeted therapies, and on-demand production of customized dosage forms, but future progress depends on expanding genomic diversity, building curated multi-omics re...

Janhavi Patil, Diya H. Aga, Sneha Yadav et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.